1cP-MiPLA

vanc 6 1cP-MIPLA.svg skin-invert-image 200px 1cP-MiPLA 3D.png bg-transparent 250px Oral Serotonin receptor modulator; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen None 3028950-74-2 170763684 128938072 1cP-MIPLA; 1-Cyclopropanoyl-MiPLA; 1-Cyclopropanoyl-N-methyl-N-isopropyllysergamide; 1-(Cyclopropanecarbonyl)-N,6-dimethyl-N-(propan-2-yl)-9,10-didehydroergoline-8β-carboxamide (6aR,9R)-4-(cyclopropanecarbonyl)-N,7-dimethyl-N-(propan-2-yl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide 24 29 3 2 CN1C[C@@H](C=C2[C@H]1Cc1cn(c3c1c2ccc3)C(=O)C1CC1)C(=O)N(C(C)C)C 1S/C24H29N3O2/c1-14(2)26(4)23(28)17-10-19-18-6-5-7-20-22(18)16(11-21(19)25(3)12-17)13-27(20)24(29)15-8-9-15/h5-7,10,13-15,17,21H,8-9,11-12H2,1-4H3/t17-,21-/m1/s1 DBIYDHUGEKMIHZ-DYESRHJHSA-N 1cP-MiPLA, also known as 1-cyclopropanoyl-MiPLA or 1-cyclopropanoyl-N-methyl-N-isopropyllysergamide, is a presumed psychedelic drug of the lysergamide family. 1cP-MIPLA АИПСИН https://aipsin.com/newsubstance/562/ ru 26 July 2025 Tanaka R, Kawamura M, Mizutani S, Kikura-Hanajiri R Analyses of LSD analogs in illegal products: The identification of 1cP-AL-LAD, 1cP-MIPLA and 1V-LSD Toxicologie Analytique et Clinique 34 3 S171 2022 10.1016/j.toxac.2022.06.295 free 2022ToxAC..34Q.171T Tanaka R, Kawamura M, Mizutani S, Kikura-Hanajiri R Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products Forensic Toxicology 41 2 294–303 2023 36809464 10310582 10.1007/s11419-023-00661-1 1860-8965 free https://link.springer.com/content/pdf/10.1007/s11419-023-00661-1.pdf 26 July 2025 It is the 1-cyclopropanoyl derivative of MiPLA (N-methyl-N-isopropyllysergamide) and is thought to be a prodrug of MiPLA. 1cP-MiPLA has been encountered as a novel designer drug online and in Japan. Use and effects MiPLA#Use and effects 1cP-MiPLA has been sold in the form of blotter tabs containing doses of 200μg per tab. Data on the effects of 1cP-MiPLA at different doses are not available. Interactions Psychedelic drug#Interactions Trip killer#Serotonergic psychedelic antidotes Pharmacology 1cP-MiPLA is assumed to act as a prodrug of MiPLA via deacylation. Relatedly, it is assumed to act as a serotonin receptor agonist, including of the serotonin 5-HT2A receptor, and to be a serotonergic psychedelic. Chemistry Analogues Analogues of 1cP-MiPLA include MiPLA, 1P-MiPLA, and 1cP-AL-LAD, among others. History 1cP-MiPLA was first encountered as a novel designer drug online in 2020 and in Japan by 2022. Society and culture Legal status Canada 1cP-MiPLA is not a controlled substance in Canada as of 2025.Controlled Drugs and Substances Act Department of Justice Canada https://laws-lois.justice.gc.ca/eng/acts/c-38.8/FullText.html 19 January 2026 Russia 1cP-MiPLA is a schedule I controlled substance in Russia. United States 1cP-MiPLA is not an explicitly controlled substance in the United States. Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) January 2026 U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division United States https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption. See also Substituted lysergamide Lizard Labs References External links 1cP-MiPLA - Isomer Design 1cP-MiPLA - PsychonautWiki Category:5-HT2A agonists Category:Carboxamides Category:Cyclopropyl compounds Category:Designer prodrugs Category:Isopropyl compounds Category:Methyl compounds Category:Psychedelic lysergamides Category:Serotonin receptor modulators Category:Dialkylamino compounds